Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Buy
246,181
+167,252
+212% +$7.47M ﹤0.01% 1545
2026
Q1
$3.8M Buy
78,929
+11,201
+17% +$522K ﹤0.01% 1924
2025
Q4
$3.28M Buy
67,728
+1,406
+2% +$69.7K ﹤0.01% 1827
2025
Q3
$3.13M Sell
66,322
-6,376
-9% -$308K ﹤0.01% 1718
2025
Q2
$3.51M Buy
72,698
+42,180
+138% +$2.16M ﹤0.01% 1468
2025
Q1
$1.69M Buy
30,518
+15,791
+107% +$855K ﹤0.01% 1705
2024
Q4
$710K Buy
14,727
+1,249
+9% +$63.5K ﹤0.01% 2072
2024
Q3
$777K Buy
13,478
+6,388
+90% +$345K ﹤0.01% 1968
2024
Q2
$344K Buy
+7,090
New +$342K ﹤0.01% 2210

Other funds holding SNY

Cliff Asness's SNY Position: Q2 2026 in Review

Cliff Asness increased its Sanofi (SNY) stake by 212% in Q2 2026, buying an estimated $7.47M and bringing the position to 246,181 shares worth $10.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Cliff Asness first reported a position in SNY in Q2 2024 and has held it in 9 quarters since. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Cliff Asness held 246,181 shares of Sanofi worth $10.5M as of Q2 2026.
  • Cliff Asness bought 167,252 Sanofi shares in Q2 2026, an estimated $7.47M.
  • Sanofi made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1545 holding.
  • Cliff Asness first reported a position in Sanofi in Q2 2024 and has held it in 9 quarters since.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.